gvtcx

PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK

ATAMIS LTD Published 9 Jun 2021 Contracts Finder

key details

Statusactive
Category (CPV) 75122000
Deadline28 Jun 2021
Contract start1 Aug 2021
Contract end31 Jul 2022
Procedureopen
SME suitableYes
OCIDocds-b5fd17-259bc4cb-69bc-4418-8b4b-6560152b97e8

description

Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will:

rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets;
monitor the emergence of a synthetic opioid market as seen in North America;
identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids.

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal. https://health-family.force.com/s/Welcome

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
29 Nov 2022 Tender amendment (tenderAmendment) · afa5f1cb-5e4e-4e1f-8cfb-697ac2e58d25-594321

more from ATAMIS LTD

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.